COVID-19 and thyrotoxicosis

  • Gabriel Quiroga
  • Liliana Clara
  • Carmen Cabezón
  • Marisa Sanchez
Keywords: COVID-19, SARS-CoV-2, Thyrocytes, Thyroid

Abstract

The infection by the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has challenged the health care system with a new spectrum of clinical manifestations and organ disfuntions, that require proper diagnosis and treatment.

In this case we report a patient with persistent tachycardia after COVID-19 acute illness. This finding led to multiple medical visits until final diagnosis of thyrotoxicosis of autoimmune etiology.

Thyrotoxicosis is an unusual complication of COVID-19, that results in higher morbility in patients during the convalescent phase of the disease. Opportune clinical suspicion and early diagnosis seems to be beneficial in terms of clinical outcome

Downloads

Download data is not yet available.

Author Biographies

Gabriel Quiroga

Infectología, Hospital Italiano de Buenos Aires, Argentina.

Liliana Clara

Infectología, Hospital Italiano de Buenos Aires, Argentina.

Carmen Cabezón

Endocrinología, Hospital Italiano de Buenos Aires, Argentina.

Marisa Sanchez

Infectología, Hospital Italiano de Buenos Aires, Argentina.

ASEI 194 Quiroga imagen
Published
2021-03-19
How to Cite
Quiroga, G., Clara, L., Cabezón, C., & Sanchez, M. (2021). COVID-19 and thyrotoxicosis. Actualizaciones En Sida E Infectología, 28(104). https://doi.org/10.52226/revista.v28i104.71
Section
Case Report